日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative effectiveness and persistence of ixekizumab and other b/tsDMARDs in patients with PsA from a real-world setting: 12-month results from the PRO-SPIRIT study

来自真实世界的研究:伊克珠单抗与其他生物/靶向合成DMARDs在银屑病关节炎患者中的疗效和持久性比较:PRO-SPIRIT研究的12个月结果

Marzo-Ortega, Helena; Sewerin, Philipp; Selmi, Carlo; Russ, Hagen; Ng, Khai Jing; Ngantcha, Marcus; Gerwien, Jens Gammeltoft; Kennedy, Dominika; Gallego-Flores, Adela; de la Torre, Inmaculada; Gladman, Dafna D; Coates, Laura C

Spinal mobility and functional limitations in patients with diffuse idiopathic skeletal hyperostosis compared to healthy controls and patients with axial spondyloarthritis

与健康对照组和中轴型脊柱关节炎患者相比,弥漫性特发性骨肥厚症患者的脊柱活动度和功能受限情况

Kiefer, David; Eisenbach, Benedikt; Redeker, Imke; Kiltz, Uta; Sewerin, Philipp; Kernder, Anna; Andreica, Ioana; Mucke, Johanna; Vossen, Diana; Baraliakos, Xenofon

Limited discriminatory value of RAMRIS findings between RA and hand osteoarthritis: a cross-sectional MRI study

RAMRIS检查结果在区分类风湿关节炎和手骨关节炎方面的鉴别价值有限:一项横断面MRI研究

Sewerin, Philipp; Kiefer, David; Arcq, Jean Maurice; Tsiami, Styliani; Mucke, Johanna; Kernder, Anna; Kiltz, Uta; Baraliakos, Xenofon

Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naïve patients in two phase 3 clinical trials

利用机器学习分析方法,结合两项 3 期临床试验中未接受过生物制剂 DMARD 治疗的患者数据,评估了 Risankizumab 对不同 PsA 表型的疗效

Gossec, Laure; Balanescu, Andra; D'Agostino, Maria Antonietta; Ogdie, Alexis; Sewerin, Philipp; Deng, Yu; Shi, Linyu; Sugimoto, Yoshiyuki; Zhong, Sheng; Xing, Yunzhao; Lippe, Ralph; Kishimoto, Mitsumasa

Real-World Prevalence, Incidence and Management of Systemic Lupus Erythematosus in Germany: A Retrospective Claims Data Analysis

德国系统性红斑狼疮的真实世界患病率、发病率和治疗情况:一项回顾性理赔数据分析

Alexander, Tobias; Sewerin, Philipp; Strangfeld, Anja; Schulte, Marcus; Borchert, Julia; Garcia, Tarcyane Barata; Schrom, Eva

Real-World Evidence for Ixekizumab in the Treatment of Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: Systematic Literature Review 2022-2023

伊克珠单抗治疗银屑病、银屑病关节炎和中轴型脊柱关节炎的真实世界证据:2022-2023年系统文献综述

Puig, Luis; Sewerin, Philipp; Schuster, Christopher; Ng, Khai Jing; Papadimitropoulos, Manny; Gadagamma, Sneha; Nuñez, Mercedes; Lampropoulou, Anastasia

Disrupted uromodulin trafficking is rescued by targeting TMED cargo receptors

通过靶向 TMED 货物受体来挽救中断的尿调节蛋白运输

Silvana Bazua-Valenti, Matthew R Brown, Jason Zavras, Magdalena Riedl Khursigara, Elizabeth Grinkevich, Eriene-Heidi Sidhom, Keith H Keller, Matthew Racette, Moran Dvela-Levitt, Catarina Quintanova, Hasan Demirci, Sebastian Sewerin, Alissa C Goss, John Lin, Hyery Yoo, Alvaro S Vaca Jacome, Malvina P

Clinically relevant differences in spinal mobility related to daytime performance in patients with axial spondyloarthritis

轴性脊柱关节炎患者日间表现相关的脊柱活动度的临床相关差异

Kiefer, David; Schneider, Lucia; Braun, Jürgen; Kiltz, Uta; Kolle, Niklas; Andreica, Ioana; Tsiami, Styliani; Buehring, Bjoern; Sewerin, Philipp; Herbold, Susanne; Baraliakos, Xenofon

No difference in clinical parameters and drug retention in PsA patients receiving b/tsDMARD monotherapy versus combination with methotrexate: data from the RABBIT-SpA registry

RABBIT-SpA 注册研究数据显示,接受生物制剂/靶向合成DMARD单药治疗与联合甲氨蝶呤治疗的PsA患者在临床参数和药物维持方面无差异:RABBIT-SpA注册研究数据

Regierer, Anne Constanze; Kiefer, David; Schett, Georg; Krause, Andreas; Weiß, Anja; Sewerin, Philipp; Strangfeld, Anja

Identification of a machine learning-based diagnostic model for axial spondyloarthritis in rheumatological routine care using a random forest approach

利用随机森林方法识别用于风湿病常规护理中轴型脊柱关节炎的机器学习诊断模型

Redeker, Imke; Tsiami, Styliani; Eicker, Jan; Kiltz, Uta; Kiefer, David; Andreica, Ioana; Sewerin, Philipp; Baraliakos, Xenofon